Pediatric hypothalamic obesity.
Phase of Trial: Phase II
Latest Information Update: 09 Sep 2011
At a glance
- Drugs Octreotide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 09 Sep 2011 Actual end date (Jul 2005) added as reported by ClinicalTrials.gov.
- 29 Sep 2009 Planned number of patients changed from 50 to 60 as reported by ClinicalTrials.gov.